ABRILUMAB
UNII Y9UQ37XT2T

Substance Identification & Data

This profile provides standardized clinical and technical data for Abrilumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Y9UQ37XT2T.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1342290-43-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
Y9UQ37XT2T
CAS Registry Number
1342290-43-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ABRILUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9921
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
AB-117
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Abrilumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ABRILUMAB

Common Names & Synonyms

ABRILUMAB [INN]
ABRILUMAB [USAN]
ABRILUMAB [WHO-DD]
IMMUNOGLOBULIN G, ANTI-(HUMAN INTEGRIN .ALPHA.4.BETA.7) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER

Technical Codes

AMG 181
AMG-181
MEDI7183
MEDI-7183